102 results
Page 3 of 6
6-K
57u68xt wmm
31 Oct 13
Current report (foreign)
12:00am
6-K
4dxh80 x5jhen01hwx0i
18 Jul 13
Current report (foreign)
12:00am
6-K
0j9yn5vgc5 gd44ocev
2 May 13
Current report (foreign)
12:00am
6-K
EX-5.1
4htg8huvti0xmuqso
18 Dec 12
Current report (foreign)
12:00am
6-K
v438kqp8
1 Nov 12
Current report (foreign)
12:00am
6-K
2enk1gis1cg
8 Aug 12
Current report (foreign)
12:00am
6-K
zqmn fjwye
2 Aug 12
Current report (foreign)
12:00am
6-K
fyb6hjtzf 3irboq5mg
9 May 12
Current report (foreign)
12:00am
6-K
EX-99.1
q14hr6t
8 May 12
Teva Appoints Michael Hayden as President of Global Research and Development and Chief Scientific Officer
12:00am
CORRESP
mfrgjn0
23 Apr 12
Correspondence with SEC
12:00am
F-3ASR
EX-5.1
ikdn pa7pepux
9 Dec 11
Automatic shelf registration (foreign)
12:00am
6-K
EX-5.1
8x2kv
10 Nov 11
Current report (foreign)
12:00am
POSASR
EX-5.7
keafdmqojc tgxg88l4
26 Aug 11
Automatic shelf registration (post-effective amendment)
12:00am
6-K
o4y5iw2cian q4qvq3t
4 Aug 11
Current report (foreign)
12:00am
POSASR
EX-5.4
27scwi1 wkb
29 Jul 11
Automatic shelf registration (post-effective amendment)
12:00am
6-K
EX-5.1
l87nzuv93e ls7gyh
21 Mar 11
Current report (foreign)
12:00am
S-8
EX-5.1
rmzvy9243p232
27 Jul 10
Registration of securities for employees
12:00am